Stem Cell Therapy Market by Product Type (Stem Cell Therapies, Stem Cell Banking, Stem Cell Ancillaries) and Forecast 2017-2021

Stem Cell Therapy Market by Product Type (Stem Cell Therapies, Stem Cell Banking, Stem Cell Ancillaries) and Forecast 2017-2021

Stem cell therapy uses stem cells to treat or prevent a disease or condition.  Stem cell research shows great promise for advancing our understanding of human biology, especially in the areas of human development, genetic and chromosomal disorders, human reproduction, and new disease therapies. Bone marrow transplant is the most widely used stem-cell therapy, whereas some therapies also use stem cells derived from umbilical cord blood for treatment of neurodegenerative diseases and conditions such as diabetes, heart disease, and to treat blood and immune system, or to restore the blood system after treatments for specific cancers. Stem cells are being studied for a number of medical applications such as neurodegeneration, brain and spinal cord injury, generation of heart muscle cells, blood-cell formation, re-growing teeth, cochlear hair cell regrowth, blindness and vision impairment, pancreatic beta cells, transplantation, orthopedics, wound healing, Infertility, and HIV/AIDS. Ancillary materials (AMs) are components or reagents used during the manufacture of cell therapy products but are not intended to be part of the final products. AMs for cell- and tissue-based therapies include serum derivatives, antibiotics, cytokines, growth factors, culture media, antibodies, and enzymes. Continued growth in the cell therapy industry and commercialization of cell therapies through clinical trials has led to increased awareness around the need for specialized and complex materials utilized for stem cell therapies.

The global stem cell therapy market segmentation is based on product type (stem cell therapies, stem cell banking, stem cell ancillaries).

The global stem cell therapy market research report provides market size (Revenue USD Million 2014 to 2021), market share analysis, growth trends and forecast (CAGR%, 2017 to 2021). The global stem cell therapy market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. In addition, the global stem cell therapy market report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries.  The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.

Major players operating in the global stem cell therapy market and profiled in this report include Aastrom Biosciences, Alliancells Bioscience Co. Ltd., AlloCure, Inc., Anterogen Co. Ltd., Astellas Pharma (Ocata Therapeutics/Advanced Cell Technology), Baxter Healthcare, Bioheart, BrainStorm Therapeutics, Caladrius Biosciences, Cardio3 Sciences, Cellonis Biotechnology, Cytori Therapeutics, FCB-Pharmicell Co. Ltd., Gamida Cell, Geron Corporation, LifeCell, Ixion Biotechnology , Medipost Co. Ltd., Mesoblast, Neuralstem, Inc., NeuroGeneration, Inc., NuVasive, Inc., Orthofix, Osiris Therapeutics, Pfizer, ReNeuron, Skye Orthbiologics, LLC, Stem Cell Therapeutics, STEMCELL Technologies, StemCells, Inc., Stemedica Cell Technologies, Inc., Stempeutics Research, TiGenix, and ViaCyte.

  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Products
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Product Type (cells, media, serum, vaccine, protein, instrument, etc.)
    • Source Type
    • Reagents and Consumables Type
    • Diagnostic Test
    • Indication Type
    • Technology
    • Diagnostics, Therapeutic or Surgical Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  8. Recommendations
  9. References

Stem Cell Therapy Market

1. Product Type
1.1. Stem Cell Therapies
1.2. Stem Cell Banking
1.3. Stem Cell Ancillaries

2. Geography
2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC)
2.5. Rest of the World

3. Company Profiles
3.1. Aastrom Biosciences
3.2. Alliancells Bioscience Co. Ltd.
3.3. AlloCure, Inc.
3.4. Anterogen Co. Ltd.
3.5. Astellas Pharma (Ocata Therapeutics/Advanced Cell Technology)
3.6. Baxter Healthcare
3.7. Bioheart
3.8. BrainStorm Therapeutics
3.9. Caladrius Biosciences
3.10. Cardio3 Sciences
3.11. Cellonis Biotechnology
3.12. Cytori Therapeutics
3.13. FCB-Pharmicell Co. Ltd.
3.14. Gamida Cell
3.15. Geron Corporation
3.16. LifeCell
3.17. Ixion Biotechnology
3.18. Medipost Co. Ltd.
3.19. Mesoblast
3.20. Neuralstem, Inc.
3.21. NeuroGeneration, Inc.
3.22. NuVasive, Inc.
3.23. Orthofix
3.24. Osiris Therapeutics
3.25. Pfizer
3.26. ReNeuron
3.27. Skye Orthbiologics, LLC
3.28. Stem Cell Therapeutics
3.29. STEMCELL Technologies
3.30. StemCells, Inc.
3.31. Stemedica Cell Technologies, Inc.
3.32. Stempeutics Research
3.33. TiGenix
3.34. ViaCyte

Request market specific full ToC and sample pages for this report

Full Name*


Phone Number* [Please add country code]



Chinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish